EF Hutton Maintains Buy on Imunon, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
EF Hutton analyst Jason Kolbert has reiterated a Buy rating for Imunon (NASDAQ:IMNN) and maintained a price target of $29.
October 31, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton analyst Jason Kolbert has reiterated a Buy rating for Imunon and maintained a price target of $29, indicating confidence in the stock's potential.
The reaffirmation of a Buy rating and a $29 price target by EF Hutton suggests a positive outlook for Imunon, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100